Zynerba Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch ZYNE and buy or sell other stocks, ETFs, and their options commission-free!

About ZYNE

AllTranz is a specialty pharmaceutical company developing a unique set of dermal delivery products utilizing two proprietary technology platforms consisting of prodrug development and microneedle formulations. AllTranz will be a leader in the development of innovative drug design strategies delivered via unique dermal product solutions to treat neurological and a variety of other disorders.

CEO

Armando Anido, MBA

CEOArmando Anido, MBA

Employees

—

Employees—

Headquarters

Devon, Pennsylvania

HeadquartersDevon, Pennsylvania

Founded

2007

Founded2007

Employees

—

Employees—

ZYNE Key Statistics

Market cap

70.12M

Market cap70.12M

Price-Earnings ratio

-1.63

Price-Earnings ratio-1.63

Dividend yield

—

Dividend yield—

Average volume

585.87K

Average volume585.87K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.40

52 Week high$1.40

52 Week low

$0.25

52 Week low$0.25